# Remote Monitoring for Equity in Advancing Control of Hypertension

Study · id `cardio:ct-nct05481892` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05481892](<https://clinicaltrials.gov/study/NCT05481892>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05481892

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 540 participants.

## Technical summary

Registry record NCT05481892. Randomized; single masking; primary purpose health services research. Start 2023-04-20 (actual); primary completion 2026-04-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 540 participants (enrolled count; ClinicalTrials.gov record NCT05481892, source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)
- Started: 2023-04-20 (actual) (ClinicalTrials.gov record NCT05481892, source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)
- Primary completion: 2026-04-16 (actual) (ClinicalTrials.gov record NCT05481892, source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)
- Completion: 2026-04-16 (actual) (ClinicalTrials.gov record NCT05481892, source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05481892, source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05481892-2026-04-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote Monitoring for Equity in Advancing Control of Hypertension
- Acronym: REACH
- Condition: Hypertension
- Intervention (Device): Cellular Home blood pressure (BP) monitoring
- Lead sponsor: University of California, San Francisco
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 8dcf33460dfdf0d0f9140759aa7e975ee44268b673a411afd770cef561a4f818
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
